These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31707394)

  • 1. Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Anti-Vascular Endothelial Growth Factor Treatment Response in Caucasians.
    Kokame GT; Liu K; Kokame KA; Kaneko KN; Omizo JN
    Ophthalmologica; 2020; 243(3):178-186. PubMed ID: 31707394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kokame GT; deCarlo TE; Kaneko KN; Omizo JN; Lian R
    Ophthalmol Retina; 2019 Sep; 3(9):744-752. PubMed ID: 31511169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT; Omizo JN; Kokame KA; Yamane ML
    Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification.
    van Dijk EHC; Mohabati D; Veselinovic S; Chung WH; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):351-361. PubMed ID: 32812132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
    Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
    Cho HJ; Kim K; Lim SH; Kang DH; Kim JW
    Br J Ophthalmol; 2020 Oct; 104(10):1443-1447. PubMed ID: 31896542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Hosokawa MM; Ouchi C; Shiode Y; Kimura S; Matoba R; Morita T; Morizane Y
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; 262(10):3099-3107. PubMed ID: 38625447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LONG-TERM COURSE AND VISUAL OUTCOMES OF PRECHOROIDAL CLEFT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Kim JH; Kim JW; Kim CG; Lee DW
    Retina; 2021 Dec; 41(12):2436-2445. PubMed ID: 34173365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.
    Ozkaya A; Alagoz C; Garip R; Alkin Z; Perente I; Yazici AT; Taskapili M
    Eye (Lond); 2016 Jul; 30(7):958-65. PubMed ID: 27080484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
    Ting DS; Ng WY; Ng SR; Tan SP; Yeo IY; Mathur R; Chan CM; Tan AC; Tan GS; Wong TY; Cheung CM
    Am J Ophthalmol; 2016 Apr; 164():128-36.e1. PubMed ID: 26743619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.
    Punjabi OS; Huang J; Rodriguez L; Lyon AT; Jampol LM; Mirza RG
    Br J Ophthalmol; 2013 Aug; 97(8):1024-31. PubMed ID: 23759437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Muakkassa NW; Chin AT; de Carlo T; Klein KA; Baumal CR; Witkin AJ; Duker JS; Waheed NK
    Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic polypoidal choroidal vasculopathy in Caucasians: The POLYON real-life study in 50 naive patients.
    El Chehab H; Kodjikian L; Lagenaite-Desmaizère C; Agard E; De Bats F; Mathis T; Dot C
    Eur J Ophthalmol; 2020 Sep; 30(5):948-955. PubMed ID: 31505993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y; Iwahashi C; Gomi F
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
    Bo Q; Yan Q; Shen M; Song M; Sun M; Yu Y; Rosenfeld PJ; Wang F; Sun X
    JAMA Ophthalmol; 2019 Jun; 137(6):642-650. PubMed ID: 30998817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.
    Inoue M; Balaratnasingam C; Freund KB
    Retina; 2015 Nov; 35(11):2265-74. PubMed ID: 26405770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
    Shin JY; Choi M; Chung B; Byeon SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.
    Alasil T; Ferrara D; Adhi M; Brewer E; Kraus MF; Baumal CR; Hornegger J; Fujimoto JG; Witkin AJ; Reichel E; Duker JS; Waheed NK
    Am J Ophthalmol; 2015 Apr; 159(4):634-43. PubMed ID: 25528955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.